Navigation Links
MannKind Corporation Reports Second Quarter Financial Results
Date:8/11/2008

- Conference Call Today at 5:00 p.m. EDT -

VALENCIA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) today reported financial results for the second quarter ended June 30, 2008.

For the second quarter of 2008, total operating expenses were $80.9 million, compared to $75.4 million for the second quarter of 2007. This increase was primarily attributable to increased research and development (R&D) expenses which totaled $67.6 million for this quarter compared to $61.5 million for the same quarter in 2007. The increase in research and development expenses for the three months ended June 30, 2008 as compared to the same period in the prior year was primarily due to increases in manufacturing costs, clinical trial costs, and stock-based compensation expense. General and administrative (G&A) expenses decreased by $0.6 million to $13.3 million for the second quarter of 2008 compared to the second quarter of 2007. The decrease in general and administrative expenses for the three months ended June 30, 2008 as compared to the same period in the prior year was primarily due to lower professional service fees, partially offset by increases in stock-based compensation expense and salary related expenses.

For the first six months of 2008, operating expenses totaled $154.9 million, compared to $152.7 million in the first half of 2007. R&D expenses for the first six months were $126.0 million, compared to $125.3 million in 2007. The increase in R&D expenses for the first six months was primarily due to increases in stock-based compensation expense and manufacturing costs, partially offset by lower clinical trial costs. G&A expenses increased by $1.5 million to $28.9 million for the first half
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
2. MannKind to Present at Upcoming Conferences
3. MannKind Corporation Reports First Quarter Financial Results
4. MannKind to Present at the Morgan Stanley Healthcare Conference
5. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
6. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
7. MannKind Corporation Response to Recent Market Events
8. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
9. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
10. MannKind to Present at the Wachovia 2008 Healthcare Conference
11. MannKind to Present at the Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DTS Language Services, Inc . is ... Portal for Life Science organizations who need document translations. ... the subject matter of their documents in advance with ... will help reduce time-to-delivery of translations, often a critical ... likelihood of error. , “All translations are inherently time-sensitive ...
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology ... signed an exclusive agreement with R-Pharm, a leading ... (Taigexyn ® ) in the Russian ... and other members of the Commonwealth Independent States ... of bacterial infections including those caused by drug-resistant ...
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and ... in the United States and ... Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of ... at the U.S. Food and Drug Administration (FDA). As the ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. ... are joining together with two institutes from the ... develop more reliable tools for bringing safer, more ... Organovo is collaborating with the National Center for ... Institute (NEI) to develop better and more clinically ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... Jan. 22 The Advisory Board Company (Nasdaq: ABCO ) ... Robert W. Musslewhite , Chief Executive Officer and Michael T. Kirshbaum ... quarter ended December 31, 2009 .  The call will be held ... Time .  The Company plans to release its third quarter financial results ...
... , EATONTOWN, N.J. , Jan. 22 ... emerging field of biologic products for regenerative healing, announced today that ... plan is designed to discourage coercive or unfair takeover tactics and ... Company in the event that an unsolicited offer is made to ...
... , , LEXINGTON, Mass. ... The Molecular Genetics Core Facility (MGCF) at Children,s Hospital ... to conduct the highly economic targeted enrichment of genes of ... receiving the Geniom RT Analyzer® from febit to perform HybSelect. ...
Cached Biology Technology:The Advisory Board Company Schedules Third Quarter Conference Call for February 4, 2010 2Osteotech, Inc. Adopts Stockholder Rights Plan 2Osteotech, Inc. Adopts Stockholder Rights Plan 3Molecular Genetics Core Facility at Children's Hospital Boston Selects HybSelect from febit for Targeted Resequencing 2Molecular Genetics Core Facility at Children's Hospital Boston Selects HybSelect from febit for Targeted Resequencing 3
(Date:3/6/2014)... highlands of South America and East Africa, cool temperatures ... bay. New research by Howard Hughes Medical Institute (HHMI) ... areas, malaria can spread to populations in higher elevations ... of being infected by malaria parasites. , HHMI ... in two mountainous regions in South America and East ...
(Date:3/6/2014)... University of Oxford suggests that higher levels of omega-3 ... algae and seafood, are associated with better sleep. The ... supplements of algal sources would improve the sleep of ... study were not selected for sleep problems, but were ... the outset, the parents filled in a child sleep ...
(Date:3/6/2014)... are duplicated every time our cells divide. Histone proteins ... crucial information that regulates our genes. Danish researchers show ... histones to DNA copying hubs in our cells. This ... our genes and prevent disease. The results are published ... Interdisciplinary research team finds cellular high-speed shuttle ...
Breaking Biology News(10 mins):Warmer temperatures fuel spread of malaria into higher elevations 2Warmer temperatures fuel spread of malaria into higher elevations 3Study suggests higher levels of omega-3 in diet are associated with better sleep 2Enzyme controls transport of genomic building blocks 2
... Researchers at The Forsyth Institute have made a ... The scientific studies led by Anne Tanner, BDS, Ph.D., ... caries (cavities). This bacterium, Scardovia wiggsiae , was ... childhood caries when other known pathogens such as ...
... the brain can be regulated by an immune system molecule, ... published Feb. 27 in the journal Nature Neuroscience , ... conditions such as schizophrenia or autism. Schizophrenia, autism ... the brain, said Kimberley McAllister, associate professor in the Center ...
... has comparable efficacy to chemotherapy, and is better ... has progressed quickly after treatment with first-line therapy, ... show. Dr Tudor Ciuleanu from the Institute ... finding from the international TITAN study at the ...
Cached Biology News:Forsyth team gains new insight on childhood dental disease 2Immune molecule regulates brain connections 2Erlotinib effective and with fewer side-effects after first-line treatment 2
Limit of detection: <5 pg/ml...
Request Info...
... provides the premium quality siRNAs you need ... can be readily ordered online by providing ... by providing the sense and antisense siRNA ... and Silencer Pre-designed siRNAs, which are already ...
Ready for formulation or direct injection into animals Provided in convenient 100, 250, 1000 and 10,000 nmol sizes HPLC purified, salt free, sterile filtered, and endotoxin tested ...
Biology Products: